Pronatalism - the argument for lots of babies
By Staff [cites CGS' Katie Hasson],
Radio New Zealand
| 04. 05. 2025
At a time where some countries are struggling with low birth rates, the voices for pronatalism are getting louder. But it’s who’s sounding the call for more babies that has people talking.
Tech giant Elon Musk has fourteen children and has expressed concern about the risk of a population collapse. Meanwhile, founder of Open AI Sam Altman also wants a big family and has invested in fertility tech, a multi-billion-dollar industry that's booming.
Katie Hasson is the associate director for The Center of Genetics and Society in the US, and talks to Susie.
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...